Oncology Success Rate in New Delhi
Access high-quality treatment through JCI & NABH-accredited hospitals, renowned specialists, and end-to-end medical travel support designed around your healing journey.
Plan My Journey
Tell us your condition and budget - our AI matches the right destination, hospital and doctor and visa pathway
Cost calculator
I know my treatment - show me cost from 3 hospitals
5K+ International Patients Treated
40+ Source Countries Served
500+ Accredited Partner Hospitals
98% Patient Satisfaction
80% Average Savings vs USA
10K+ Doctors
NABH, JCI Accredited Hospitals
Free Treatment Plan
Free Consultation with Doctor
5+ Destinations Covered
Written by DivinHeal Editorial Contributor, DivinHeal Medical Team, Healthcare Advisory Team Published on: February 19, 2026
About
Oncology Success Rate in New Delhi | Outcomes Data
Understanding the Oncology success rate in New Delhi is crucial for patients considering treatment. Success rates depend significantly on the cancer type, stage at diagnosis, specific treatment protocols, and individual patient health profiles. This information helps patients and their families make confident and informed healthcare decisions regarding their care journey.
Oncology outcomes in New Delhi are derived from aggregated clinical data and rigorous treatment-level evaluations. These success rates are reviewed to ensure comparisons with national and international benchmarks. However, outcomes consistently vary based on the specific treatment method, the disease stage, and unique patient characteristics, necessitating careful consideration of individual circumstances.
Defining Success in Oncology Treatment
In oncology, "success" can signify various positive outcomes, including complete remission, effective disease control, significant tumor reduction, or extended progression-free survival. It also encompasses improved quality of life and long-term survival. Understanding the difference between short-term responses and long-term recovery is vital for a comprehensive view of treatment efficacy.
Oncology Success Rate Breakdown by Treatment Type
Success rates vary depending on treatment approach and patient factors.
| Treatment Type / Category | Typical Use Case | Success Rate Range (%) | What Success Indicates |
|---|---|---|---|
| Surgery | Early-stage localized tumors | 60%–90% | Complete tumor removal, disease-free status |
| Chemotherapy | Systemic cancers, adjuvant/neoadjuvant therapy | 30%–70% | Tumor shrinkage, disease control, extended survival |
| Radiation Therapy | Localized tumors, palliative care | 50%–85% | Local tumor control, symptom relief |
| Immunotherapy | Advanced or refractory cancers | 20%–60% | Durable response, long-term remission in some cases |
| Targeted Therapy | Cancers with specific genetic mutations | 40%–80% | Significant response, slowed disease progression |
Stage-wise Oncology Survival Rate in New Delhi
The stage of cancer at diagnosis is a primary determinant of treatment prognosis and is carefully evaluated. This stage-wise Oncology survival rate in New Delhi reflects common trends observed across various cancer types, highlighting the importance of early detection and intervention for improving patient outcomes.
| Cancer Stage | Typical Treatment Approach | Survival Rate Range (%) |
|---|---|---|
| Stage I (Early) | Surgery, localized radiation | 70%–95% |
| Stage II (Local) | Surgery, adjuvant chemotherapy/radiation | 50%–80% |
| Stage III (Regional) | Multimodal therapy, systemic treatments | 30%–60% |
| Stage IV (Metastatic) | Systemic therapies, palliative care | 5%–30% |
Oncology Survival Rate by Age in New Delhi
Patient age significantly impacts treatment tolerance and overall outcomes, influencing the Oncology survival rate by age in New Delhi. Younger patients often tolerate aggressive treatments better, while older adults may face comorbidities that necessitate modified approaches. This aligns with internationally observed clinical trends in oncology.
| Age Group | General Prognosis Factor | Survival Rate Range (%) |
|---|---|---|
| Under 40 years | Often higher tolerance, better recovery potential | 60%–85% |
| 40–65 years | Good treatment response, varying with health status | 45%–75% |
| Over 65 years | Potential comorbidities, modified treatment plans | 25%–55% |
New Delhi vs. Global Oncology Survival Rate Comparison
Oncology success rates in New Delhi are generally comparable with international standards when similar protocols, advanced technology, and patient selection criteria are applied. Leading centers such as AIIMS, Tata Memorial Centre, and major institutes follow evidence-based protocols.
| Country | Oncology Survival Rate Range (%) |
|---|---|
| New Delhi (India) | 40%–70% |
| United States | 45%–75% |
| United Kingdom | 40%–70% |
| Germany | 45%–70% |
| Singapore | 50%–75% |
| Canada | 40%–70% |
| Australia | 45%–75% |
These ranges are indicative and subject to variation based on specific cancer types, individual patient conditions, and the precise treatment approaches utilized. They are not guarantees of individual outcomes.
Key Factors Influencing Oncology Recovery Rate in New Delhi
- Type and aggressiveness of the cancer
- Stage of the cancer at the time of diagnosis
- Overall health and presence of other medical conditions (comorbidities)
- Age of the patient and their ability to tolerate treatment
- Response to initial treatments and absence of previous treatments
- Access to advanced diagnostic tools and personalized treatment plans
- Nutritional status and lifestyle factors
Data Sources & Methodology for Oncology Outcomes
- National Cancer Registries and Population-Based Cancer Registries
- World Health Organization (WHO) and International Agency for Research on Cancer (IARC) reports
- Peer-reviewed medical journals and large-scale clinical trials
- Aggregated multi-hospital outcome data from accredited cancer centers
Informed Oncology Decisions
Understanding these outcome trends empowers patients to engage meaningfully with their medical teams. This knowledge supports making well-considered, data-based choices about their oncology care.
Hospitals
NABH & JCI Accredited Hospitals in India,Turkey, Thailand & UAE.
Artemis Hospital
Sector 51, Gurugram, Haryana, India
Lokmanya Hospitals
Not Specified
White Lotus Hospital
766, SFS 3145, SFS Road, 7th Sector, HSR Layout, Bengaluru, Karnataka 560102, India
Institute of Brain and Spine (IBS Hospital)
Not Specified
Meet Our Medical Specialists
Sr. Consultant - Urology & Kidney Transplant Program (Unit I)
Dr. Abhinandan Mukhopadhyay
MBBS, MD
India
Sr. Consultant - Urology & Kidney Transplant Program (Unit I)
Dr. Abhinandan Mukhopadhyay
MBBS, MD
India
How DivinHeal Helps
We simplify your medical journey by providing comprehensive support and access to world-class healthcare.
Expert Specialist Matching
Connecting you with the world's top-rated medical experts.
Accredited Hospital Network
Access to JCI & NABH certified healthcare facilities.
Complete Travel Coordination
Hassle-free visa, stay, and local transport assistance.
24/7 Personal Care
Dedicated patient advisors supporting you at every step.
Journey Guidance
Full guidance from start to end of the patient treatment journey.
Expert Specialist Matching
Connecting you with the world's top-rated medical experts.
Everything you
need to know today
Browse through these common inquiries to better understand our patient-focused medical platform.
Yes, we work with a variety of insurance providers. Contact our team to verify your coverage.
Yes, we provide secure online consultations with experienced specialists.
Our care coordinators help match you with the most suitable specialist.
Absolutely. Your medical information is protected according to healthcare privacy standards.
Look at six things: accreditation (JCI or NABH), specialty depth, doctor credentials and experience, procedure-specific success rates, international patient support, and technology. DivinHeal's AI-driven matching evaluates every hospital in our accredited partner network on these dimensions and shortlists the best-fit options for your condition, budget, and country.
JCI (Joint Commission International) is the US-based global gold standard for hospital quality, recognised worldwide. NABH is India's national accreditation — accredited by ISQua, the same body that accredits JCI. Both signal independently verified safety and quality. Most of India's leading hospitals hold both.
Yes. All three welcome international patients through structured medical visa programs. India is the most established, treating patients from Africa, the Middle East, and South Asia at 60–80% lower cost. Thailand leads in cosmetic and dental care. The UAE is emerging in oncology and reproductive medicine.
Most patients save 50–80% on treatment costs. Heart bypass costs US $7,000–9,000 in India compared to $70,000–150,000 in the US. IVF costs $3,000–4,500 compared to $12,000–20,000 in the UK. Even after flights, visa, and accommodation, total savings remain 60–70%.
DivinHeal manages your entire non-medical journey: visa invitation letters, medical visa guidance, doctor appointments, teleconsultations, airport pickup, hospital-vetted accommodation for you and your attendant, language interpreters, local transport, cuisine preferences, and post-treatment follow-up — one dedicated coordinator from first enquiry to final follow-up.
You need a valid passport (6+ months validity), a medical visa (M-Visa for India — DivinHeal provides the hospital invitation letter), return flight tickets, recent medical reports and a doctor's referral, current prescription list, and proof of financial means. Any accompanying attendant needs their own passport and MX-Visa.
Still have more questions?
Book a call with our friendly team to learn how DivineHeal simplifies your healthcare journey.